La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Cognition (drug effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cognition < Cognition (drug effects) < Cognition (physiology)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000004 (????) F. Tison [France] ; J. Lecaroz ; L. Letenneur ; J F DartiguesParkinsonism and exposure to neuroleptic drugs in elderly people living in institutions.
000110 (2000) N. Fournet [France] ; O. Moreaud ; J L Roulin ; B. Naegele ; J. PellatWorking memory functioning in medicated Parkinson's disease patients and the effect of withdrawal of dopaminergic medication.
000129 (2000) B. Pillon [France] ; C. Ardouin ; P. Damier ; P. Krack ; J L Houeto ; H. Klinger ; A M Bonnet ; P. Pollak ; A L Benabid ; Yves Agid [France]Neuropsychological changes between "off" and "on" STN or GPi stimulation in Parkinson's disease.
000348 (2003) H. Mollion [France] ; J. Ventre-Dominey ; P F Dominey ; E. BroussolleDissociable effects of dopaminergic therapy on spatial versus non-spatial working memory in Parkinson's disease.
000401 (2003) A. Courtière [France] ; J. Hardouin ; A. Goujon ; F. Vidal ; T. HasbroucqSelective effects of low-dose dopamine D1 and D2 receptor antagonists on rat information processing.
000584 (2006) Djamel Ben Smaïl [France] ; Christiane Samuel ; Karine Rouy-Thenaisy ; Joelle Régnault ; Philippe AzouviBromocriptine in traumatic brain injury.
000637 (2006) Nathalie Turle-Lorenzo [France] ; Béatrice Maurin ; Carole Puma ; Claire Chezaubernard ; Philippe Morain ; Christelle Baunez ; André Nieoullon ; Marianne AmalricThe dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
000A43 (2009) C. Ardouin [France] ; I. Chéreau ; P-M Llorca ; E. Lhommée ; F. Durif ; P. Pollak ; P. Krack[Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease].
001117 (2003) Patrice Boyer [France]Sense and non-sense of polypharmacy: increasing efficacy, decreasing compliance?
001153 (2013) Karim Fifel [France] ; Ouria Dkhissi-Benyahya ; Howard M. CooperLack of long-term changes in circadian, locomotor, and cognitive functions in acute and chronic MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) mouse models of Parkinson's disease.
001A40 (1989) B. Pillon [France] ; B. Dubois ; A M Bonnet ; M. Esteguy ; J. Guimaraes ; J M Vigouret ; F. Lhermitte ; Yves Agid [France]Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test.
001D01 (1994) J C Delumeau [France] ; D. Bentué-Ferrer ; J M Gandon ; R. Amrein ; S. Belliard ; H. AllainMonoamine oxidase inhibitors, cognitive functions and neurodegenerative diseases.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Cognition (drug effects)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Cognition (drug effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Cognition (drug effects)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024